摘要
肺癌根据组织病理学特征分为不同类型,其中80%~85%为非小细胞肺癌,目前早期非小细胞肺癌的治疗手段以手术切除、放射治疗辅助为主,晚期以化学治疗联合免疫治疗或靶向治疗为主。影像组学检测方法的出现为非小细胞肺癌的影像诊断和定性检测及疗效评价提供了新的技术手段,在其检测与定性、疗效评估等方面具有优势。本文现就影像组学在非小细胞肺癌的疗效预测、制定个体化诊疗方案,并为实现精准医疗提供帮助等临床应用做一综述。
Lung cancer is classified into different types according to histopathological characteristics,of which 80%-85%are non-small cell lung cancer.Currently,the treatment of early stage non-small cell lung cancer is mainly based on surgical resection and adjuvant radiotherapy,and chemotherapy combined with immunotherapy or targeted therapy is mainly used in the late stage.The emergence of imaging histology provides a new technical means for the imaging diagnosis and qualitative detection of non-small cell lung cancer and the evaluation of therapeutic efficacy,and has advantages in its detection and characterization,as well as in the evaluation of therapeutic efficacy.This paper reviews the clinical applications of imaging histology in predicting the efficacy of non-small cell lung cancer,formulating individualized diagnostic and treatment plans,and providing assistance in realizing precision medicine.
作者
刘宇婷
赵磊
刘挨师
LIU Yuting;ZHAO Lei;LIU Aishi(First School of Clinical Medicine,Inner Mongolia Medical University,Hohhot 010050,China;Department of Imaging Diagnosis,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)
出处
《分子影像学杂志》
2024年第5期553-557,共5页
Journal of Molecular Imaging
基金
内蒙古自治区自然科学基金(2022SHZR2186)。
关键词
影像组学
非小细胞肺癌
治疗方式
疗效预测
imaging histology
non-small cell lung cancer
treatment modalities
efficacy prediction
